US › Healthcare

Fractyl Health, Inc. Common Stock (GUTS)

US · Healthcare · Biotechnology

$0.59+5.03%

Last close · 2026-09-17

Latest quarter · ended 2026-06-30

Revenue

Net profit

$-25.5M

EPS

$-0.12

EPS estimate

$-0.15

EPS came in at -0.12 against a street estimate of -0.15 — a beat of 20.0%.

Key statistics

Market cap

$89.5M

Forward P/E

0.0

P/B

5.06

Book value

$-0.01

EPS (TTM)

$-0.91

52-week high

$2.44

52-week low

$0.38

50-day MA

$0.72

200-day MA

$0.95

Beta

2.33

Analyst view

Analysts rate Fractyl Health, Inc. Common Stock a strong buy (4 buy, 0 hold, 0 sell out of 4) with an average price target of $5.03.

Shareholding

Insiders

1.40%

Institutions

51.51%

Largest institutional holders

Fund	Stake
Nantahala Capital Management, LLC	8.40%
683 Capital Management LLC	4.23%
Catalio Capital Management, LP	3.88%
Vanguard Capital Management, LLC	3.48%
Pale Fire Capital SE	3.14%
General Catalyst Group Management, LLC	3.07%
Deer Management Co. LLC	3.00%
Maverick Capital Ltd	2.50%

See the full picture

Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for Fractyl Health, Inc. Common Stock — free to start.

Google Play App Store

Other Healthcare companies

Eli Lilly and Company Johnson & Johnson AbbVie Inc Merck & Company Inc UnitedHealth Group Incorporated Novartis AG ADR AstraZeneca PLC Thermo Fisher Scientific Inc Amgen Inc Novo Nordisk A/S Gilead Sciences Inc Abbott Laboratories

Data updated 2026-09-18.